Lixte Biotechnology Ownership | Who Owns Lixte Biotechnology?
Lixte Biotechnology Ownership Summary
Lixte Biotechnology is owned by 1.49% institutional investors, and 98.51% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.37% of its assets in Lixte Biotechnology shares.
LIXT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lixte Biotechnology | 1.49% | - | 98.51% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | -90.91% | 248,084 | -54.71% | 1 | 1376.60% | - | -100.00% | - | -100.00% |
| Mar 31, 2023 | 11 | -26.67% | 547,770 | -23.02% | - | 162.63% | 5 | -16.67% | 3 | - |
| Dec 31, 2022 | 15 | 15.38% | 711,577 | 9.67% | - | 296.02% | 6 | - | 3 | 200.00% |
| Sep 30, 2022 | 13 | -7.14% | 648,856 | -25.66% | - | 134.26% | 6 | -14.29% | 1 | -75.00% |
| Jun 30, 2022 | 14 | 27.27% | 872,865 | -27.88% | - | 69.51% | 7 | 75.00% | 4 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 16.98K | 0.37% | -120.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 5.38K | 0.18% | 170.00 |
| Fidelity Series Total Market Index | 2.83K | 0.06% | - |
| Spartan Total Market Index Pool G | 1.50K | 0.03% | 1.50K |
| Fidelity Nasdaq Composite Index | 775.00 | 0.02% | - |
| Spartan Extended Market Index Pool E | 244.00 | 0.01% | 72.00 |
| SSgA U.S. Extended Market Index Class I | 190.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - L | 215.00 | 0.01% | - |
| Northern Trust Extended Eq Market Idx | 215.00 | 0.01% | - |
| State St US Extended Mkt Indx NL Cl C | 190.00 | 0.00% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2023 Q4 | 5 | - |
LIXT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools